Antimicrobial Agents Practice Questions

Q: Ganciclovir is used in the treatment of which of the following viral infections?

Cytomegalovirus. **Explanation:** **Ganciclovir** is a synthetic analogue of 2'-deoxyguanosine and is the **drug of choice** for infections caused by **Cytomegalovirus (CMV)**. ### 1. Why Cytomegalovirus (CMV) is Correct: Ganciclovir’s mechanism of action is highly specific to CMV. Inside a CMV-infected cell, the viral protein kinase **UL97** catalyzes the initial phosphorylation of Ganciclovir to Ganciclovir-monophosphate. Host cell enzymes then convert it into the triphosphate form, which competitively inhibits **viral DNA polymerase** and terminates DNA chain elongation. Because it requires the specific UL97 kinase for activation, it is significantly more potent against CMV than Acyclovir. ### 2. Why Other Options are Incorrect: * **Adenovirus:** While some severe cases are treated with Cidofovir or Brincidofovir, Ganciclovir is not the standard treatment. * **Epstein-Barr virus (EBV):** Although Ganciclovir has some *in vitro* activity against EBV, it is rarely used clinically for EBV as the virus lacks the specific kinases required for efficient drug activation. * **Arenavirus:** This family (e.g., Lassa fever) consists of RNA viruses. Ganciclovir only targets DNA viruses. **Ribavirin** is the drug of choice for Arenaviruses. ### 3. High-Yield Clinical Pearls for NEET-PG: * **Major Side Effect:** The dose-limiting toxicity of Ganciclovir is **Bone Marrow Suppression** (specifically neutropenia and thrombocytopenia). * **Valganciclovir:** This is the L-valyl ester prodrug of Ganciclovir with high oral bioavailability, used for CMV prophylaxis and maintenance. * **Resistance:** Resistance to Ganciclovir occurs due to mutations in the **UL97 gene** (preventing phosphorylation) or the **UL54 gene** (mutating DNA polymerase). * **Foscarnet:** Used as an alternative in Ganciclovir-resistant CMV; it does not require viral phosphorylation for its action.

Q: Which anti-tuberculosis drugs are safe in hepatic failure?

Streptomycin and Ethambutol. ### Explanation **Core Concept: Drug Metabolism and Hepatotoxicity** The management of tuberculosis in patients with hepatic failure requires selecting drugs that are not metabolized by the liver and lack hepatotoxic potential. Most first-line anti-tubercular drugs (ATD) are hepatotoxic, but **Streptomycin** and **Ethambutol** are the notable exceptions [2]. **Why Option C is Correct:** * **Ethambutol:** It is primarily excreted unchanged in the urine (approx. 80%). It does not undergo significant hepatic metabolism and is not considered hepatotoxic [3]. * **Streptomycin:** As an aminoglycoside, it is highly polar and is excreted entirely unchanged via glomerular filtration in the kidneys. It has no hepatic metabolism, making it safe for the liver (though it requires dose adjustment in renal failure) [2]. **Why Other Options are Incorrect:** * **Isoniazid (H), Rifampicin (R), and Pyrazinamide (Z):** These are the "Big Three" hepatotoxic drugs [1]. * **Pyrazinamide** is the most hepatotoxic of all first-line agents [1]. * **Isoniazid** produces toxic metabolites (acetylhydrazine) via the NAT2 pathway. * **Rifampicin** can cause cholestatic jaundice and induces microsomal enzymes. * Therefore, any option containing H, R, or Z (Options A, B, and D) is incorrect for a patient with hepatic failure. **High-Yield Clinical Pearls for NEET-PG:** * **Order of Hepatotoxicity:** Pyrazinamide > Isoniazid > Rifampicin. * **Safe Regimen in Liver Disease:** In patients with unstable/severe liver disease, the WHO recommends a "Hepatosafe Regimen" typically consisting of **Streptomycin, Ethambutol, and a Fluoroquinolone** (like Levofloxacin). * **Monitoring:** If ALT/AST levels rise >3 times the upper limit of normal with symptoms, or >5 times without symptoms, hepatotoxic drugs must be stopped immediately [1].

Q: What is the basis for combining Ritonavir with Lopinavir?

CYP3A4 inhibition by Ritonavir. **Explanation:** The combination of Lopinavir and Ritonavir is a classic example of **pharmacokinetic boosting**. **1. Why Option B is Correct:** Lopinavir is a potent Protease Inhibitor (PI) used in HIV treatment, but it is rapidly metabolized by the hepatic enzyme **CYP3A4**, leading to poor oral bioavailability and sub-therapeutic plasma levels when used alone. Ritonavir, while also a PI, is a **potent irreversible inhibitor of CYP3A4**. When added in low doses to Lopinavir, Ritonavir "boosts" the plasma concentration of Lopinavir by blocking its metabolism. This allows for lower dosing frequency and improved efficacy. **2. Why Other Options are Incorrect:** * **Option A:** While they are pharmaceutically compatible in a single tablet (Kaletra), this is a result of the combination's utility, not the pharmacological basis for it. * **Option C:** Ritonavir actually has a relatively short half-life; its value lies in its enzyme-inhibiting potency, not its own persistence in the body. * **Option D:** Ritonavir does not counteract Lopinavir's side effects; in fact, Ritonavir itself often adds to gastrointestinal distress and lipid elevations. **High-Yield Clinical Pearls for NEET-PG:** * **"Booster" Effect:** Ritonavir is used at "sub-therapeutic" doses (100–200 mg) specifically for enzyme inhibition, not for its own antiviral activity. * **Cobicistat:** Another drug used solely as a pharmacokinetic enhancer (CYP3A4 inhibitor) without any intrinsic antiviral activity. * **Drug Interactions:** Because Ritonavir inhibits CYP3A4, it has significant interactions with other drugs metabolized by this pathway (e.g., statins, benzodiazepines, and rifampin).

Q: What is the drug of choice for malaria in pregnancy?

Chloroquine. **Explanation:** The management of malaria in pregnancy is a high-yield topic for NEET-PG, as it requires balancing maternal efficacy with fetal safety. **1. Why Chloroquine is the Correct Answer:** Chloroquine remains the **drug of choice (DOC)** for the treatment of uncomplicated malaria caused by *Plasmodium vivax* or chloroquine-sensitive *P. falciparum* in all trimesters of pregnancy. It is considered safe, non-teratogenic, and has a well-established safety profile for the developing fetus. In areas where *P. vivax* is prevalent, it effectively targets the erythrocytic stages. **2. Analysis of Incorrect Options:** * **Proguanil (A):** While safe in pregnancy, it is rarely used as monotherapy for treatment due to slow action and high resistance. It is typically used for prophylaxis in combination with Atovaquone (Malarone), which is generally avoided in pregnancy unless benefits outweigh risks. * **Artemisinin (C):** While ACT (Artemisinin-based Combination Therapy) is the DOC for chloroquine-resistant malaria in the 2nd and 3rd trimesters, Chloroquine is still the primary answer for "malaria in pregnancy" unless resistance is specified. Note: Quinine + Clindamycin is preferred for resistant cases in the 1st trimester. * **Halofantrine (D):** This drug is **contraindicated** in pregnancy due to potential embryotoxicity and its known risk of QT interval prolongation (cardiotoxicity). **3. Clinical Pearls for NEET-PG:** * **Vivax Malaria:** Chloroquine is the DOC. However, **Primaquine is strictly contraindicated** in pregnancy due to the risk of fetal hemolysis (G6PD status of the fetus is unknown). * **Falciparum (Resistant) Malaria:** * *1st Trimester:* Quinine + Clindamycin (7 days). * *2nd & 3rd Trimester:* ACT (Artemether-Lumefantrine is most common). * **Severe Malaria:** IV Artesunate is the DOC for all trimesters, as the risk of maternal death outweighs potential fetal risks.

Q: Acyclovir triphosphate inhibits the synthesis of DNA by competing with which of the following?

2'-deoxyguanosine triphosphate. ### Explanation **Mechanism of Action:** Acyclovir is a guanosine analog. To become active, it must undergo three stages of phosphorylation. The first step is catalyzed by viral **thymidine kinase**, converting it to acyclovir monophosphate. Host cell kinases then convert it into the active form, **acyclovir triphosphate**. Acyclovir triphosphate inhibits viral DNA synthesis via two mechanisms: 1. **Competitive Inhibition:** It acts as a structural analog of **deoxyguanosine triphosphate (dGTP)**. It competes with dGTP for the viral DNA polymerase enzyme. 2. **Chain Termination:** Once incorporated into the growing DNA strand, it acts as a "terminator" because it lacks the **3'-hydroxyl group** necessary for the attachment of the next nucleotide. **Analysis of Options:** * **Option C (Correct):** Acyclovir is a synthetic analog of guanine; therefore, its triphosphate form competes specifically with the natural substrate **2'-deoxyguanosine triphosphate (dGTP)**. * **Option A & B:** Adenosine analogs (like Vidarabine) would compete with adenosine nucleotides, not guanosine analogs like Acyclovir. * **Option D:** 4'-deoxyguanosine triphosphate is not the standard physiological substrate for DNA polymerase; the natural building block is the 2'-deoxy form. **High-Yield Clinical Pearls for NEET-PG:** * **Selectivity:** Acyclovir is highly selective because the initial phosphorylation requires **viral thymidine kinase**, which is absent in non-infected host cells. * **Resistance:** Most commonly occurs due to the loss of viral thymidine kinase activity (seen in immunocompromised patients). * **Drug of Choice:** For Herpes Simplex Virus (HSV) encephalitis, genital herpes, and Varicella-Zoster Virus (VZV) infections. * **Adverse Effect:** Obstructive crystalline nephropathy (prevented by adequate hydration).

Q: Absorption of which of the following antimalarial drugs increases with food intake?

Mefloquine. **Explanation:** The correct answer is **Mefloquine**. **Why Mefloquine is correct:** Mefloquine is a highly lipophilic antimalarial drug. The presence of **food, particularly high-fat meals**, significantly enhances its oral bioavailability and rate of absorption. This is a critical pharmacokinetic property because Mefloquine has a very long half-life (approx. 2–3 weeks); ensuring optimal initial absorption is vital for therapeutic efficacy. In clinical practice, patients are advised to take Mefloquine with a meal and a full glass of water to maximize absorption and minimize gastrointestinal irritation. **Why the other options are incorrect:** * **Artesunate (B):** This is a water-soluble artemisinin derivative. It is rapidly absorbed and metabolized to dihydroartemisinin. Its absorption is not significantly dependent on food intake. * **Chloroquine (C):** Chloroquine is almost completely and rapidly absorbed from the gastrointestinal tract regardless of food. While taking it with food may reduce GI upset, it does not significantly increase its bioavailability. * **Amodiaquine (D):** Similar to Chloroquine, it is well-absorbed orally, and its pharmacokinetics are not clinically altered by food intake to the extent seen with Mefloquine. **High-Yield NEET-PG Pearls:** * **Lumefantrine & Halofantrine:** Like Mefloquine, these drugs also show a **marked increase** in absorption when taken with fatty food. (Remember: "Fatty food favors Halofantrine/Lumefantrine/Mefloquine"). * **Atovaquone:** Another antimalarial where fatty food increases bioavailability by up to 3-fold. * **Mefloquine Side Effects:** High-yield for exams are its neuropsychiatric adverse effects (hallucinations, anxiety, and psychosis) and its contraindication in patients with epilepsy or psychiatric disorders.

Q: Which of the following statements about fluoroquinolones is true?

All of the above.. Fluoroquinolones (FQs) are a vital class of bactericidal antibiotics that inhibit DNA synthesis by targeting **DNA gyrase** (Gram-negative) and **Topoisomerase IV** (Gram-positive). **Explanation of Options:** * **Option A:** Ciprofloxacin is indeed the **Drug of Choice (DOC)** for both the prophylaxis and treatment of *Bacillus anthracis* (Anthrax). While doxycycline is an alternative, FQs are preferred due to their high efficacy. * **Option B:** Among the commonly used FQs, Ciprofloxacin and Levofloxacin are the primary agents with significant **anti-pseudomonal** activity. Ciprofloxacin is the most potent against *Pseudomonas aeruginosa*, while newer "respiratory quinolones" like Moxifloxacin lack reliable activity against this pathogen. * **Option C:** The classification of FQs is based on their spectrum. **First-generation** agents (e.g., Norfloxacin) have a narrow spectrum, primarily targeting Gram-negative aerobes, and are largely restricted to treating urinary tract infections (UTIs). **Why "All of the Above" is correct:** Each statement accurately describes a fundamental pharmacological property or clinical application of the fluoroquinolone class. **High-Yield NEET-PG Pearls:** * **Respiratory Quinolones:** Levofloxacin, Moxifloxacin, and Gemifloxacin are called "respiratory quinolones" due to enhanced activity against *S. pneumoniae*. * **Moxifloxacin:** It is the only FQ primarily excreted via the **biliary route**; therefore, it does not require dose adjustment in renal failure but cannot be used for UTIs. * **Adverse Effects:** Watch for **tendon rupture** (Achilles tendon), QT prolongation, and dysglycemia. They are generally contraindicated in pregnancy and children due to **cartilage toxicity**.

Q: Oral vancomycin may be given in which of the following conditions?

Pseudomembranous colitis. **Explanation:** **Vancomycin** is a glycopeptide antibiotic that is poorly absorbed from the gastrointestinal tract (GIT) when administered orally. While this poor bioavailability makes it unsuitable for systemic infections, it is highly advantageous for treating local infections within the gut. **Why Option D is Correct:** **Pseudomembranous colitis** is caused by an overgrowth of *Clostridioides difficile* (C. diff), usually following broad-spectrum antibiotic use. Because oral vancomycin remains concentrated in the intestinal lumen and is not absorbed into the bloodstream, it acts directly on the bacteria in the colon. It is currently a first-line treatment for C. diff infections. **Why Other Options are Incorrect:** * **A & C (Plague and Tularemia):** Both are caused by Gram-negative bacteria (*Yersinia pestis* and *Francisella tularensis*, respectively). Vancomycin is only active against Gram-positive organisms. Furthermore, these are systemic infections requiring drugs with high systemic bioavailability (e.g., Streptomycin, Gentamicin, or Doxycycline). * **B (Prostatitis):** This is a systemic/tissue-level infection. Oral vancomycin would never reach the prostate due to lack of absorption from the gut. **NEET-PG High-Yield Pearls:** * **Mechanism of Action:** Inhibits bacterial cell wall synthesis by binding to the **D-Ala-D-Ala** terminus of nascent peptidoglycan pentapeptide. * **Route of Administration:** Given **IV** for systemic infections (e.g., MRSA) and **Orally** *only* for *C. difficile* colitis. * **Adverse Effects:** "Red Man Syndrome" (infusion-related histamine release; prevented by slow infusion), nephrotoxicity, and ototoxicity. * **Drug of Choice:** Vancomycin is the gold standard for **MRSA** (Methicillin-resistant *Staphylococcus aureus*).

Question 1

What is the drug of choice for syphilis?

Accepted Answer

Benzathine Penicillin

Answer

Penicillin

Answer

Tetracycline

Answer

Ciprofloxacin

Question 2

Time-dependent killing and prolonged post-antibiotic effect is a characteristic of which class of antibiotics?

Accepted Answer

Beta-lactam antibiotics

Answer

Fluoroquinolones

Answer

Clindamycin

Answer

Erythromycin

Question 3

Ganciclovir is used in the treatment of which of the following viral infections?

Accepted Answer

Cytomegalovirus

Answer

Adenovirus

Answer

Epstein-Barr virus

Answer

Arenavirus

Question 4

Which anti-tuberculosis drugs are safe in hepatic failure?

Accepted Answer

Streptomycin and Ethambutol

Answer

Pyrazinamide and ethambutol

Answer

Isoniazid and Rifampicin

Answer

Rifampicin and Streptomycin

Question 5

What is the basis for combining Ritonavir with Lopinavir?

Accepted Answer

CYP3A4 inhibition by Ritonavir

Answer

Pharmaceutical compatibility

Answer

Long elimination half-life of Ritonavir

Answer

Ability to counteract side effects of Lopinavir

Question 6

What is the drug of choice for malaria in pregnancy?

Accepted Answer

Chloroquine

Answer

Proguanil

Answer

Artemesin

Answer

Halofantrine

Question 7

Acyclovir triphosphate inhibits the synthesis of DNA by competing with which of the following?

Accepted Answer

2'-deoxyguanosine triphosphate

Answer

4-Oxyadenosine monophosphate

Answer

2-Oxyadenosine diphosphate

Answer

4'-deoxyguanosine triphosphate

Question 8

Absorption of which of the following antimalarial drugs increases with food intake?

Accepted Answer

Mefloquine

Answer

Artesunate

Answer

Chloroquine

Answer

Amodiaquine

Question 9

Which of the following statements about fluoroquinolones is true?

Accepted Answer

All of the above.

Answer

Ciprofloxacin is the drug of choice for Anthrax.

Answer

Ciprofloxacin and levofloxacin are the only fluoroquinolones effective against Pseudomonas.

Answer

First-generation fluoroquinolones have a narrow spectrum of action.

Question 10

Oral vancomycin may be given in which of the following conditions?

Accepted Answer

Pseudomembranous colitis

Answer

Plague

Answer

Prostatitis

Answer

Tularemia

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?